Axogen Inc vs Mondaycom Ltd — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while Mondaycom Ltd trades at $82.82 (market cap $3.51B). The key difference: Mondaycom Ltd is the larger of the two by market cap, and Axogen Inc is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals.
| AXGN | MNDY | |
|---|---|---|
Market Cap | $2.06B | $3.51B |
Sector | Technology | Technology |
52-Week High | $46.19 | $292.24 |
52-Week Low | $11.28 | $58.81 |
Enterprise Value | $1.98B | $2.47B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Monday.com (MNDY) trades at $86.84, up 5.3% in the past 24 hours, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings expectations, with Q1 2026 EPS of $1.15 surpassing the $0.96 estimate. Revenue grew to $1.23 billion in 2025, though net income remained flat at $119 million year-over-year. Recent news highlights investor attention amid a 51% decline in the first half of 2026, with some viewing the dip as a buying opportunity due to solid fundamentals.
The outlook for MNDY is positive, driven by robust revenue growth, high gross margins of 89.05%, and a unanimous analyst buy consensus with a $115.50 price target. Key risks include elevated valuation multiples, competitive pressures in the SaaS space, and volatility from AI disruption concerns. Investors should weigh the company's execution against its premium pricing.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →